What Is a Hot-Spot and Does It Matter?

What Is a Hot-Spot and Does It Matter?
The importance of hot-spotsAs discussed in the recent post on managing tumor heterogeneity, it is widely considered best practice to determine the Ki-67 proliferative index in a hot-spot of biomarker expression. A growing body of scientific evidence ...
Read more

Managing Tumor Heterogeneity for Quantification of Biomarker Response

Managing Tumor Heterogeneity for Quantification of Biomarker Response
Tumor heterogeneity in research and diagnosticsDiagnostic pathologists and scientists often rely on tissue data for important diagnostic-, research-, or even business- decisions. One of the major concerns relate to tumor heterogeneity in the context ...
Read more

Deep Learning Methods Powered by AI in Tissue Image Analysis

Deep Learning Methods Powered by AI in Tissue Image Analysis
From tedious manual annotation work to fully automated annotations with a streamlined image analysis workflow. This is now possible with AI tools that are remarkably accurate generating powerful results within tissue segmentation, cell identification...
Read more

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology
Hørsholm, Denmark, May 3rd - Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning ...
Read more

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational pathology
• Breast cancer patients in Europe are set to benefit from more objective diagnosis • Philips’ digital pathology offering to be complemented with Visiopharm breast cancer panel algorithms Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,...
Read more

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow
Today ISENET and Visiopharm announce a non-exclusive world-wide distribution agreement to provide Visiopharm image analysis with the Galileo TMA instrument, along with the Visiopharm Tissuearray™ imaging module, a part of ONCOTOPIX®, for tissue-ba...
Read more